Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy

PaperCitations, authors & open-access status

A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 79 citations, 2012 year and closed oa status.

79
Citations
2012
Year
closed
OA Status

Related on ScholarIQ

Puyuan Xing
Author
Esophageal Cancer Research and Treatment
Topic
Esophageal Cancer Research and Treatment
Topic
Lung Cancer Treatments and Mutations
Topic
Pancreatic and Hepatic Oncology Research
Topic
470M+ articles · free account